US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease reut.rs/4nrGScF
US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease
Fortress Biotech on Wednesday said the U.S. Food and Drug Administration declined to approve the drug it is developing with Indian drugmaker Zydus Lifesciences for treating a type of rare genetic disease in children.
reut.rs
October 1, 2025 at 12:40 PM
US FDA declines to approve Fortress Bio and Zydus' treatment for a rare pediatric disease reut.rs/4nrGScF
Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology
oncodaily.com/opinion/agen...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Agenus #Zydus #IO #Immuno-Oncology
oncodaily.com/opinion/agen...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Agenus #Zydus #IO #Immuno-Oncology
Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology - OncoDaily
Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology / Agenus, biotech, botensilimab, cancer, cancer care, Cancer
oncodaily.com
June 10, 2025 at 9:06 PM
Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology
oncodaily.com/opinion/agen...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Agenus #Zydus #IO #Immuno-Oncology
oncodaily.com/opinion/agen...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Agenus #Zydus #IO #Immuno-Oncology
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease reut.rs/4btVEfQ
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for a type of rare genetic disease in children, Fortress said on Tuesday.
reut.rs
January 13, 2026 at 1:05 PM
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease reut.rs/4btVEfQ
Zydus to launch generic semaglutide injections in India after patent expiry in March reut.rs/4kTHJm1
Zydus to launch generic semaglutide injections in India after patent expiry in March
Zydus Lifesciences will launch generic versions of semaglutide injections for obesity and diabetes in India after patent expiry of the Ozempic active ingredient in late March, it said on Wednesday.
reut.rs
February 25, 2026 at 6:10 PM
Zydus to launch generic semaglutide injections in India after patent expiry in March reut.rs/4kTHJm1
India's Zydus Life reports higher quarterly profit on new drug launches in US reut.rs/3YSA11S
India's Zydus Life reports higher quarterly profit on new drug launches in US
Indian drugmaker Zydus Lifesciences reported a higher adjusted fourth-quarter profit on Tuesday, driven by new drug launches in the U.S., its biggest market.
reut.rs
May 20, 2025 at 8:45 AM
India's Zydus Life reports higher quarterly profit on new drug launches in US reut.rs/3YSA11S
• Mylan: $284,447,916
• Hikma: $95,818,293
• Amneal: $71,751,010
• Apotex: $63,682,369
• Indivior: $38,022,450
• Sun: $30,992,087
• Alvogen: $18,680,162
• Zydus: $14,859,220
These drugmakers callously profited off the rampant overprescribing and misuse of dangerously addictive opioids.
• Hikma: $95,818,293
• Amneal: $71,751,010
• Apotex: $63,682,369
• Indivior: $38,022,450
• Sun: $30,992,087
• Alvogen: $18,680,162
• Zydus: $14,859,220
These drugmakers callously profited off the rampant overprescribing and misuse of dangerously addictive opioids.
July 10, 2025 at 6:58 PM
• Mylan: $284,447,916
• Hikma: $95,818,293
• Amneal: $71,751,010
• Apotex: $63,682,369
• Indivior: $38,022,450
• Sun: $30,992,087
• Alvogen: $18,680,162
• Zydus: $14,859,220
These drugmakers callously profited off the rampant overprescribing and misuse of dangerously addictive opioids.
• Hikma: $95,818,293
• Amneal: $71,751,010
• Apotex: $63,682,369
• Indivior: $38,022,450
• Sun: $30,992,087
• Alvogen: $18,680,162
• Zydus: $14,859,220
These drugmakers callously profited off the rampant overprescribing and misuse of dangerously addictive opioids.
India's Zydus, Lupin sign deal to co‑market Semaglutide injections reut.rs/4uuaiLn
India's Zydus, Lupin sign deal to co‑market Semaglutide injections
Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on Tuesday to co‑market semaglutide injections in the country ahead of the ingredient's patent expiry.
reut.rs
March 17, 2026 at 11:01 AM
India's Zydus, Lupin sign deal to co‑market Semaglutide injections reut.rs/4uuaiLn
"Aš žydus gelbėjau, nes visi pasaulio proletarai vienas kitam broliai, o jūs ką?"
August 3, 2026 at 9:39 AM
"Aš žydus gelbėjau, nes visi pasaulio proletarai vienas kitam broliai, o jūs ką?"
Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL
oncodaily.com/insight/zydu...
#Agenus #BOT/BAL #Cancer #OncoDaily #Oncology #ZydusGroup #Health #Medicine
oncodaily.com/insight/zydu...
#Agenus #BOT/BAL #Cancer #OncoDaily #Oncology #ZydusGroup #Health #Medicine
Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL - OncoDaily
Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL / Agenus, BOT/BAL, cancer,
oncodaily.com
June 4, 2025 at 10:30 AM
Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL
oncodaily.com/insight/zydu...
#Agenus #BOT/BAL #Cancer #OncoDaily #Oncology #ZydusGroup #Health #Medicine
oncodaily.com/insight/zydu...
#Agenus #BOT/BAL #Cancer #OncoDaily #Oncology #ZydusGroup #Health #Medicine
The FDA has approved generic vumerity produced by Zydus Lifesciences multiplesclerosisnewstoday.com/news-posts/2...
FDA approves generic version of Vumerity for relapsing MS
Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.
multiplesclerosisnewstoday.com
November 26, 2025 at 9:24 PM
The FDA has approved generic vumerity produced by Zydus Lifesciences multiplesclerosisnewstoday.com/news-posts/2...
The money is part of multistate settlements with Purdue Pharma, Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus.
Another $122M from opioid settlements now available to Washington
More than 100 local governments in Washington are now eligible to claim their share of $122.2 million in settlements with Purdue Pharma and eight generic opioid manufacturers, the Washington state att...
www.kuow.org
July 29, 2025 at 6:14 PM
The money is part of multistate settlements with Purdue Pharma, Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus.
Guten Morgen, heute vor 85 Jahren wurde Litauen von den deutschen Nazis besetzt. Sofort wurde damit begonnen die Juden umzubringen. Zu viele Litauer wollten es den Deutschen recht machen, beteiligten sich am Morden der Nachbarn.
Hofften sich so von den Sowjets zu befreien?
lrt.lt/naujienos/ku...
Hofften sich so von den Sowjets zu befreien?
lrt.lt/naujienos/ku...
Sužiedėlis apie lietuvių dalyvavimą Holokauste: kaltės nejaučiu – jaučiu gėdą
85 metai nuo to sekmadienio ryto, kai Vokietija įsiveržia į Lietuvą ir pradeda naikinti žydus. Nacių okupantus sutinka p...
lrt.lt
June 23, 2026 at 3:11 AM
Guten Morgen, heute vor 85 Jahren wurde Litauen von den deutschen Nazis besetzt. Sofort wurde damit begonnen die Juden umzubringen. Zu viele Litauer wollten es den Deutschen recht machen, beteiligten sich am Morden der Nachbarn.
Hofften sich so von den Sowjets zu befreien?
lrt.lt/naujienos/ku...
Hofften sich so von den Sowjets zu befreien?
lrt.lt/naujienos/ku...
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for children with a rare genetic disorder that impairs copper absorption, Fortress said on Tuesday.
US FDA approves Fortress Bio and Zydus' treatment for a rare pediatric disease
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for children with a rare genetic disorder that impairs copper absorption, Fortress said on Tuesday.
reut.rs
January 13, 2026 at 6:25 PM
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for children with a rare genetic disorder that impairs copper absorption, Fortress said on Tuesday.
i switched to generic lamotrigine by zydus and ive been having some nasty side effects thats making it impossible to hang onto my head lately and im sleeping more than normal - im not sure if i can get the brand name filled when i go in mon as it was just filled but im not sure this vers. is good
January 24, 2025 at 4:28 PM
i switched to generic lamotrigine by zydus and ive been having some nasty side effects thats making it impossible to hang onto my head lately and im sleeping more than normal - im not sure if i can get the brand name filled when i go in mon as it was just filled but im not sure this vers. is good
When you are receiving cancer treatment that costs tens of thousands and the drug company gives you a gift of lip balm and a beanie. So grateful 🙏
#fuckcapitalism #fuckcancer
#fuckcapitalism #fuckcancer
February 28, 2025 at 12:16 PM
When you are receiving cancer treatment that costs tens of thousands and the drug company gives you a gift of lip balm and a beanie. So grateful 🙏
#fuckcapitalism #fuckcancer
#fuckcapitalism #fuckcancer
Best Cancer Hospital in Ahmedabad | Zydus Hospitals
𝖹𝗒𝖽𝗎𝗌 𝖢𝖺𝗇𝖼𝖾𝗋 𝖧𝗈𝗌𝗉𝗂𝗍𝖺𝗅 and Zydus Vadodara, have grown to become the trusted hub for comprehensive cancer care in Gujarat.
Contact Us : 7874412345
Website : zydushospitals.com
𝖹𝗒𝖽𝗎𝗌 𝖢𝖺𝗇𝖼𝖾𝗋 𝖧𝗈𝗌𝗉𝗂𝗍𝖺𝗅 and Zydus Vadodara, have grown to become the trusted hub for comprehensive cancer care in Gujarat.
Contact Us : 7874412345
Website : zydushospitals.com
July 20, 2026 at 7:30 AM
Best Cancer Hospital in Ahmedabad | Zydus Hospitals
𝖹𝗒𝖽𝗎𝗌 𝖢𝖺𝗇𝖼𝖾𝗋 𝖧𝗈𝗌𝗉𝗂𝗍𝖺𝗅 and Zydus Vadodara, have grown to become the trusted hub for comprehensive cancer care in Gujarat.
Contact Us : 7874412345
Website : zydushospitals.com
𝖹𝗒𝖽𝗎𝗌 𝖢𝖺𝗇𝖼𝖾𝗋 𝖧𝗈𝗌𝗉𝗂𝗍𝖺𝗅 and Zydus Vadodara, have grown to become the trusted hub for comprehensive cancer care in Gujarat.
Contact Us : 7874412345
Website : zydushospitals.com
World’s first Precision Fermentation dairy protein manufacturing facility begins construction in India 🇮🇳 Why care? India produces 9.5% of the world's cow milk! 🥛
Sterling Biotech To Build First-Ever Precision Fermentation Dairy Protein Factory In Gujarat
Sterling Biotech, a joint venture between Perfect Day and Zydus, has begun construction of the world’s first precision fermentation-based dairy protein manufacturing facility. The foundation stone was...
bwhealthcareworld.com
January 8, 2025 at 4:41 AM
World’s first Precision Fermentation dairy protein manufacturing facility begins construction in India 🇮🇳 Why care? India produces 9.5% of the world's cow milk! 🥛
Advanced Heart Health Solutions at Zydus Hospitals
Zydus Hospitals stands at the forefront of cardiac care, offering comprehensive services that encompass diagnosis, treatment, and rehabilitation.
🌐 Website: www.zydushospitals.com
📞 Call: +91 7874412345
Zydus Hospitals stands at the forefront of cardiac care, offering comprehensive services that encompass diagnosis, treatment, and rehabilitation.
🌐 Website: www.zydushospitals.com
📞 Call: +91 7874412345
Best Multispeciality Hospital in Ahmedabad | Zydus Hospitals
Delivering quality healthcare in Ahmedabad, Zydus Hospital combines multispeciality expertise, modern medical advancements, and personalized patient care.
www.zydushospitals.com
July 15, 2026 at 8:32 AM
Advanced Heart Health Solutions at Zydus Hospitals
Zydus Hospitals stands at the forefront of cardiac care, offering comprehensive services that encompass diagnosis, treatment, and rehabilitation.
🌐 Website: www.zydushospitals.com
📞 Call: +91 7874412345
Zydus Hospitals stands at the forefront of cardiac care, offering comprehensive services that encompass diagnosis, treatment, and rehabilitation.
🌐 Website: www.zydushospitals.com
📞 Call: +91 7874412345
Zydus focuses on holistic Parkinson’s care, combining medication, therapy, and patient support for better quality of life.
#parkinsonsdisease #Zydus #healthcare #patientcare #NeurologyCare
Read blog for more information- zydushospitals.com/blog/beyond-...
#parkinsonsdisease #Zydus #healthcare #patientcare #NeurologyCare
Read blog for more information- zydushospitals.com/blog/beyond-...
Beyond Medication: Zydus Approach to Parkinson’s Care
Discover how Zydus goes beyond medication in Parkinson’s care with holistic treatments, advanced therapies, and patient-focused support for better living.
zydushospitals.com
October 4, 2025 at 11:45 AM
Zydus focuses on holistic Parkinson’s care, combining medication, therapy, and patient support for better quality of life.
#parkinsonsdisease #Zydus #healthcare #patientcare #NeurologyCare
Read blog for more information- zydushospitals.com/blog/beyond-...
#parkinsonsdisease #Zydus #healthcare #patientcare #NeurologyCare
Read blog for more information- zydushospitals.com/blog/beyond-...
Pipeline – Beyond whey, Perfect Day has filed patents to express casein proteins and dairy fats in microbes, aiming for fully “cow-complete” analogues in the next few years. Partnerships with pharma (Zydus) and CPG giants (Nestlé, Mars, Bel) suggest a strategy of licensing rather than building.
May 1, 2025 at 9:36 AM
Pipeline – Beyond whey, Perfect Day has filed patents to express casein proteins and dairy fats in microbes, aiming for fully “cow-complete” analogues in the next few years. Partnerships with pharma (Zydus) and CPG giants (Nestlé, Mars, Bel) suggest a strategy of licensing rather than building.